MAP2K3 Antikörper (AA 99-343)
MAP2K3
Reaktivität: Human
WB, IHC, IP, IF/ICC
Wirt: Kaninchen
Polyclonal
unconjugated
Produktnummer ABIN2915017
-
-
Target
Alle MAP2K3 Antikörper anzeigen
-
MAP2K3
(Mitogen-Activated Protein Kinase Kinase 3 (MAP2K3))
-
Bindungsspezifität
-
AA 99-343
-
Reaktivität
-
Human
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser MAP2K3 Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (fixed cells) (IF/ICC)
-
Aufreinigung
-
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
Immunogen
-
MAP2K3 (Val99-Leu343)
-
Top Product
-
Discover our top product MAP2K3 Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Format
-
Liquid
-
Konzentration
-
500 μg/mL
-
Buffer
-
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
-
Konservierungsmittel
-
ProClin
-
Vorsichtsmaßnahmen
-
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
-
4 °C,-20 °C
-
Informationen zur Lagerung
-
Store at 4 °C for frequent use. Aliquot and store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
-
-
Target
-
MAP2K3
(Mitogen-Activated Protein Kinase Kinase 3 (MAP2K3))
-
Andere Bezeichnung
-
Mitogen Activated Protein Kinase Kinase 3 (MAP2K3 Produkte)
-
Synonyme
-
MAPKK3 antikoerper, MEK3 antikoerper, MKK3 antikoerper, PRKMK3 antikoerper, SAPKK-2 antikoerper, SAPKK2 antikoerper, AW212142 antikoerper, Prkmk3 antikoerper, mMKK3b antikoerper, Mkk3 antikoerper, mitogen-activated protein kinase kinase 3 antikoerper, mitogen activated protein kinase kinase 3 antikoerper, MAP kinase activator XMEK3 antikoerper, MAP2K3 antikoerper, Map2k3 antikoerper, map2k3 antikoerper
-
Pathways
-
MAPK Signalweg, TLR Signalweg, Activation of Innate immune Response, Toll-Like Receptors Cascades, Autophagie, Signaling Events mediated by VEGFR1 and VEGFR2
-